Where Will Nu Holdings Stock Be in 2030?
Despite fast growth, high profitability and an extraordinary runway ahead,…
Sell
19
LABU Quote, Financials, Valuation and Earnings
Last price:
$59.40
Seasonality move
:
23.6%
Day range:
$53.67 - $60.75
52-week range:
$53.67 - $152.60
Dividend yield:
0.47%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
3.4M
Avg. volume:
1.2M
1-year change:
-57.52%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
LABU
Direxion Daily S&P Biotech Bull 3X Shares
|
-- | -- | -- | -- | -- |
|
DPST
Direxion Daily Regional Banks Bull 3X Shares
|
-- | -- | -- | -- | -- |
|
DRN
Direxion Daily Real Estate Bull 3X Shares
|
-- | -- | -- | -- | -- |
|
EDC
Direxion Daily MSCI Emerging Markets Bull 3x Shs
|
-- | -- | -- | -- | -- |
|
FAS
Direxion Daily Financial Bull 3x Shares
|
-- | -- | -- | -- | -- |
|
SSO
ProShares Ultra S&P500
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
LABU
Direxion Daily S&P Biotech Bull 3X Shares
|
$54.33 | -- | -- | -- | $0.11 | 0.47% | -- |
|
DPST
Direxion Daily Regional Banks Bull 3X Shares
|
$84.76 | -- | -- | -- | $0.48 | 1.92% | -- |
|
DRN
Direxion Daily Real Estate Bull 3X Shares
|
$10.35 | -- | -- | -- | $0.06 | 2.35% | -- |
|
EDC
Direxion Daily MSCI Emerging Markets Bull 3x Shs
|
$31.09 | -- | -- | -- | $0.44 | 3.55% | -- |
|
FAS
Direxion Daily Financial Bull 3x Shares
|
$157.43 | -- | -- | -- | $0.46 | 0.78% | -- |
|
SSO
ProShares Ultra S&P500
|
$83.31 | -- | -- | -- | $0.17 | 0.93% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
LABU
Direxion Daily S&P Biotech Bull 3X Shares
|
-- | 4.035 | -- | -- |
|
DPST
Direxion Daily Regional Banks Bull 3X Shares
|
-- | 4.680 | -- | -- |
|
DRN
Direxion Daily Real Estate Bull 3X Shares
|
-- | 3.073 | -- | -- |
|
EDC
Direxion Daily MSCI Emerging Markets Bull 3x Shs
|
-- | 0.412 | -- | -- |
|
FAS
Direxion Daily Financial Bull 3x Shares
|
-- | 3.094 | -- | -- |
|
SSO
ProShares Ultra S&P500
|
-- | 1.999 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
LABU
Direxion Daily S&P Biotech Bull 3X Shares
|
-- | -- | -- | -- | -- | -- |
|
DPST
Direxion Daily Regional Banks Bull 3X Shares
|
-- | -- | -- | -- | -- | -- |
|
DRN
Direxion Daily Real Estate Bull 3X Shares
|
-- | -- | -- | -- | -- | -- |
|
EDC
Direxion Daily MSCI Emerging Markets Bull 3x Shs
|
-- | -- | -- | -- | -- | -- |
|
FAS
Direxion Daily Financial Bull 3x Shares
|
-- | -- | -- | -- | -- | -- |
|
SSO
ProShares Ultra S&P500
|
-- | -- | -- | -- | -- | -- |
Direxion Daily S&P Biotech Bull 3X Shares vs. Competitors
-
Which has Higher Returns LABU or DPST?
Direxion Daily Regional Banks Bull 3X Shares has a net margin of -- compared to Direxion Daily S&P Biotech Bull 3X Shares's net margin of --. Direxion Daily S&P Biotech Bull 3X Shares's return on equity of -- beat Direxion Daily Regional Banks Bull 3X Shares's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital LABUDirexion Daily S&P Biotech Bull 3X Shares-- -- -- DPSTDirexion Daily Regional Banks Bull 3X Shares-- -- -- -
What do Analysts Say About LABU or DPST?
Direxion Daily S&P Biotech Bull 3X Shares has a consensus price target of --, signalling downside risk potential of --. On the other hand Direxion Daily Regional Banks Bull 3X Shares has an analysts' consensus of -- which suggests that it could fall by --. Given that Direxion Daily S&P Biotech Bull 3X Shares has higher upside potential than Direxion Daily Regional Banks Bull 3X Shares, analysts believe Direxion Daily S&P Biotech Bull 3X Shares is more attractive than Direxion Daily Regional Banks Bull 3X Shares.
Company Buy Ratings Hold Ratings Sell Ratings LABUDirexion Daily S&P Biotech Bull 3X Shares0 0 0 DPSTDirexion Daily Regional Banks Bull 3X Shares0 0 0 -
Is LABU or DPST More Risky?
Direxion Daily S&P Biotech Bull 3X Shares has a beta of 3.007, which suggesting that the stock is 200.703% more volatile than S&P 500. In comparison Direxion Daily Regional Banks Bull 3X Shares has a beta of 2.548, suggesting its more volatile than the S&P 500 by 154.808%.
-
Which is a Better Dividend Stock LABU or DPST?
Direxion Daily S&P Biotech Bull 3X Shares has a quarterly dividend of $0.11 per share corresponding to a yield of 0.47%. Direxion Daily Regional Banks Bull 3X Shares offers a yield of 1.92% to investors and pays a quarterly dividend of $0.48 per share. Direxion Daily S&P Biotech Bull 3X Shares pays -- of its earnings as a dividend. Direxion Daily Regional Banks Bull 3X Shares pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios LABU or DPST?
Direxion Daily S&P Biotech Bull 3X Shares quarterly revenues are --, which are smaller than Direxion Daily Regional Banks Bull 3X Shares quarterly revenues of --. Direxion Daily S&P Biotech Bull 3X Shares's net income of -- is lower than Direxion Daily Regional Banks Bull 3X Shares's net income of --. Notably, Direxion Daily S&P Biotech Bull 3X Shares's price-to-earnings ratio is -- while Direxion Daily Regional Banks Bull 3X Shares's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Direxion Daily S&P Biotech Bull 3X Shares is -- versus -- for Direxion Daily Regional Banks Bull 3X Shares. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income LABUDirexion Daily S&P Biotech Bull 3X Shares-- -- -- -- DPSTDirexion Daily Regional Banks Bull 3X Shares-- -- -- --
-
Which has Higher Returns LABU or DRN?
Direxion Daily Real Estate Bull 3X Shares has a net margin of -- compared to Direxion Daily S&P Biotech Bull 3X Shares's net margin of --. Direxion Daily S&P Biotech Bull 3X Shares's return on equity of -- beat Direxion Daily Real Estate Bull 3X Shares's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital LABUDirexion Daily S&P Biotech Bull 3X Shares-- -- -- DRNDirexion Daily Real Estate Bull 3X Shares-- -- -- -
What do Analysts Say About LABU or DRN?
Direxion Daily S&P Biotech Bull 3X Shares has a consensus price target of --, signalling downside risk potential of --. On the other hand Direxion Daily Real Estate Bull 3X Shares has an analysts' consensus of -- which suggests that it could fall by --. Given that Direxion Daily S&P Biotech Bull 3X Shares has higher upside potential than Direxion Daily Real Estate Bull 3X Shares, analysts believe Direxion Daily S&P Biotech Bull 3X Shares is more attractive than Direxion Daily Real Estate Bull 3X Shares.
Company Buy Ratings Hold Ratings Sell Ratings LABUDirexion Daily S&P Biotech Bull 3X Shares0 0 0 DRNDirexion Daily Real Estate Bull 3X Shares0 0 0 -
Is LABU or DRN More Risky?
Direxion Daily S&P Biotech Bull 3X Shares has a beta of 3.007, which suggesting that the stock is 200.703% more volatile than S&P 500. In comparison Direxion Daily Real Estate Bull 3X Shares has a beta of 2.850, suggesting its more volatile than the S&P 500 by 184.978%.
-
Which is a Better Dividend Stock LABU or DRN?
Direxion Daily S&P Biotech Bull 3X Shares has a quarterly dividend of $0.11 per share corresponding to a yield of 0.47%. Direxion Daily Real Estate Bull 3X Shares offers a yield of 2.35% to investors and pays a quarterly dividend of $0.06 per share. Direxion Daily S&P Biotech Bull 3X Shares pays -- of its earnings as a dividend. Direxion Daily Real Estate Bull 3X Shares pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios LABU or DRN?
Direxion Daily S&P Biotech Bull 3X Shares quarterly revenues are --, which are smaller than Direxion Daily Real Estate Bull 3X Shares quarterly revenues of --. Direxion Daily S&P Biotech Bull 3X Shares's net income of -- is lower than Direxion Daily Real Estate Bull 3X Shares's net income of --. Notably, Direxion Daily S&P Biotech Bull 3X Shares's price-to-earnings ratio is -- while Direxion Daily Real Estate Bull 3X Shares's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Direxion Daily S&P Biotech Bull 3X Shares is -- versus -- for Direxion Daily Real Estate Bull 3X Shares. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income LABUDirexion Daily S&P Biotech Bull 3X Shares-- -- -- -- DRNDirexion Daily Real Estate Bull 3X Shares-- -- -- --
-
Which has Higher Returns LABU or EDC?
Direxion Daily MSCI Emerging Markets Bull 3x Shs has a net margin of -- compared to Direxion Daily S&P Biotech Bull 3X Shares's net margin of --. Direxion Daily S&P Biotech Bull 3X Shares's return on equity of -- beat Direxion Daily MSCI Emerging Markets Bull 3x Shs's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital LABUDirexion Daily S&P Biotech Bull 3X Shares-- -- -- EDCDirexion Daily MSCI Emerging Markets Bull 3x Shs-- -- -- -
What do Analysts Say About LABU or EDC?
Direxion Daily S&P Biotech Bull 3X Shares has a consensus price target of --, signalling downside risk potential of --. On the other hand Direxion Daily MSCI Emerging Markets Bull 3x Shs has an analysts' consensus of -- which suggests that it could fall by --. Given that Direxion Daily S&P Biotech Bull 3X Shares has higher upside potential than Direxion Daily MSCI Emerging Markets Bull 3x Shs, analysts believe Direxion Daily S&P Biotech Bull 3X Shares is more attractive than Direxion Daily MSCI Emerging Markets Bull 3x Shs.
Company Buy Ratings Hold Ratings Sell Ratings LABUDirexion Daily S&P Biotech Bull 3X Shares0 0 0 EDCDirexion Daily MSCI Emerging Markets Bull 3x Shs0 0 0 -
Is LABU or EDC More Risky?
Direxion Daily S&P Biotech Bull 3X Shares has a beta of 3.007, which suggesting that the stock is 200.703% more volatile than S&P 500. In comparison Direxion Daily MSCI Emerging Markets Bull 3x Shs has a beta of 1.858, suggesting its more volatile than the S&P 500 by 85.787%.
-
Which is a Better Dividend Stock LABU or EDC?
Direxion Daily S&P Biotech Bull 3X Shares has a quarterly dividend of $0.11 per share corresponding to a yield of 0.47%. Direxion Daily MSCI Emerging Markets Bull 3x Shs offers a yield of 3.55% to investors and pays a quarterly dividend of $0.44 per share. Direxion Daily S&P Biotech Bull 3X Shares pays -- of its earnings as a dividend. Direxion Daily MSCI Emerging Markets Bull 3x Shs pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios LABU or EDC?
Direxion Daily S&P Biotech Bull 3X Shares quarterly revenues are --, which are smaller than Direxion Daily MSCI Emerging Markets Bull 3x Shs quarterly revenues of --. Direxion Daily S&P Biotech Bull 3X Shares's net income of -- is lower than Direxion Daily MSCI Emerging Markets Bull 3x Shs's net income of --. Notably, Direxion Daily S&P Biotech Bull 3X Shares's price-to-earnings ratio is -- while Direxion Daily MSCI Emerging Markets Bull 3x Shs's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Direxion Daily S&P Biotech Bull 3X Shares is -- versus -- for Direxion Daily MSCI Emerging Markets Bull 3x Shs. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income LABUDirexion Daily S&P Biotech Bull 3X Shares-- -- -- -- EDCDirexion Daily MSCI Emerging Markets Bull 3x Shs-- -- -- --
-
Which has Higher Returns LABU or FAS?
Direxion Daily Financial Bull 3x Shares has a net margin of -- compared to Direxion Daily S&P Biotech Bull 3X Shares's net margin of --. Direxion Daily S&P Biotech Bull 3X Shares's return on equity of -- beat Direxion Daily Financial Bull 3x Shares's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital LABUDirexion Daily S&P Biotech Bull 3X Shares-- -- -- FASDirexion Daily Financial Bull 3x Shares-- -- -- -
What do Analysts Say About LABU or FAS?
Direxion Daily S&P Biotech Bull 3X Shares has a consensus price target of --, signalling downside risk potential of --. On the other hand Direxion Daily Financial Bull 3x Shares has an analysts' consensus of -- which suggests that it could fall by --. Given that Direxion Daily S&P Biotech Bull 3X Shares has higher upside potential than Direxion Daily Financial Bull 3x Shares, analysts believe Direxion Daily S&P Biotech Bull 3X Shares is more attractive than Direxion Daily Financial Bull 3x Shares.
Company Buy Ratings Hold Ratings Sell Ratings LABUDirexion Daily S&P Biotech Bull 3X Shares0 0 0 FASDirexion Daily Financial Bull 3x Shares0 0 0 -
Is LABU or FAS More Risky?
Direxion Daily S&P Biotech Bull 3X Shares has a beta of 3.007, which suggesting that the stock is 200.703% more volatile than S&P 500. In comparison Direxion Daily Financial Bull 3x Shares has a beta of 2.905, suggesting its more volatile than the S&P 500 by 190.494%.
-
Which is a Better Dividend Stock LABU or FAS?
Direxion Daily S&P Biotech Bull 3X Shares has a quarterly dividend of $0.11 per share corresponding to a yield of 0.47%. Direxion Daily Financial Bull 3x Shares offers a yield of 0.78% to investors and pays a quarterly dividend of $0.46 per share. Direxion Daily S&P Biotech Bull 3X Shares pays -- of its earnings as a dividend. Direxion Daily Financial Bull 3x Shares pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios LABU or FAS?
Direxion Daily S&P Biotech Bull 3X Shares quarterly revenues are --, which are smaller than Direxion Daily Financial Bull 3x Shares quarterly revenues of --. Direxion Daily S&P Biotech Bull 3X Shares's net income of -- is lower than Direxion Daily Financial Bull 3x Shares's net income of --. Notably, Direxion Daily S&P Biotech Bull 3X Shares's price-to-earnings ratio is -- while Direxion Daily Financial Bull 3x Shares's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Direxion Daily S&P Biotech Bull 3X Shares is -- versus -- for Direxion Daily Financial Bull 3x Shares. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income LABUDirexion Daily S&P Biotech Bull 3X Shares-- -- -- -- FASDirexion Daily Financial Bull 3x Shares-- -- -- --
-
Which has Higher Returns LABU or SSO?
ProShares Ultra S&P500 has a net margin of -- compared to Direxion Daily S&P Biotech Bull 3X Shares's net margin of --. Direxion Daily S&P Biotech Bull 3X Shares's return on equity of -- beat ProShares Ultra S&P500's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital LABUDirexion Daily S&P Biotech Bull 3X Shares-- -- -- SSOProShares Ultra S&P500-- -- -- -
What do Analysts Say About LABU or SSO?
Direxion Daily S&P Biotech Bull 3X Shares has a consensus price target of --, signalling downside risk potential of --. On the other hand ProShares Ultra S&P500 has an analysts' consensus of -- which suggests that it could fall by --. Given that Direxion Daily S&P Biotech Bull 3X Shares has higher upside potential than ProShares Ultra S&P500, analysts believe Direxion Daily S&P Biotech Bull 3X Shares is more attractive than ProShares Ultra S&P500.
Company Buy Ratings Hold Ratings Sell Ratings LABUDirexion Daily S&P Biotech Bull 3X Shares0 0 0 SSOProShares Ultra S&P5000 0 0 -
Is LABU or SSO More Risky?
Direxion Daily S&P Biotech Bull 3X Shares has a beta of 3.007, which suggesting that the stock is 200.703% more volatile than S&P 500. In comparison ProShares Ultra S&P500 has a beta of 2.010, suggesting its more volatile than the S&P 500 by 101.001%.
-
Which is a Better Dividend Stock LABU or SSO?
Direxion Daily S&P Biotech Bull 3X Shares has a quarterly dividend of $0.11 per share corresponding to a yield of 0.47%. ProShares Ultra S&P500 offers a yield of 0.93% to investors and pays a quarterly dividend of $0.17 per share. Direxion Daily S&P Biotech Bull 3X Shares pays -- of its earnings as a dividend. ProShares Ultra S&P500 pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios LABU or SSO?
Direxion Daily S&P Biotech Bull 3X Shares quarterly revenues are --, which are smaller than ProShares Ultra S&P500 quarterly revenues of --. Direxion Daily S&P Biotech Bull 3X Shares's net income of -- is lower than ProShares Ultra S&P500's net income of --. Notably, Direxion Daily S&P Biotech Bull 3X Shares's price-to-earnings ratio is -- while ProShares Ultra S&P500's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Direxion Daily S&P Biotech Bull 3X Shares is -- versus -- for ProShares Ultra S&P500. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income LABUDirexion Daily S&P Biotech Bull 3X Shares-- -- -- -- SSOProShares Ultra S&P500-- -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is it Too Late to Buy United Airlines Stock?
United Airlines (NASDAQ:UAL) has thoroughly outpaced the broader stock market…
3 Smartest Dividend Stocks to Buy Now
When the market entered a correction in February and March,…
Stock Ideas
Buy
56
Is AAPL Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 37x
Sell
46
Is MSFT Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 32x
Sell
42
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 37x
Alerts
Buy
78
GATE alert for Apr 2
Marblegate Acquisition [GATE] is up 86.64% over the past day.
Buy
52
NUTX alert for Apr 2
Nutex Health [NUTX] is up 5.41% over the past day.
Buy
75
CORT alert for Apr 2
Corcept Therapeutics [CORT] is down 8.84% over the past day.
